Provides a structured framework for matching specific interventional modalities to distinct benign central airway stenosis phenotypes.
Abstract
Lung volume reduction procedures are an established evidence-based aspect of chronic obstructive pulmonary disease (COPD) care. We conducted a research prioritisation exercise involving people with COPD and healthcare professionals across a range of disciplines, to identify a clear set of 10 questions to guide the development of research proposals in this area. Priorities were identified using an iterative approach based on the James Lind Alliance methodology. The final set of 10 priorities address the identification, assessment and optimisation of patients with COPD prior to any procedure, how lung volume reduction procedures are conducted and how care after the procedure has taken place should be organised.
Keep reading
N opens the next oneProvides helpful clinical context for managing tracheostomy-related airway complications commonly encountered in IP practice.
Relevant to airway management and post-procedural tracheostomy care handled by interventional pulmonologists.
Highlights the translational challenges in bronchoscopic airway disease treatments and clinical trial design.
Highlights the balance between achieving clinical benefit in COPD symptom reduction and managing bronchoscopy-related adverse events with TLD.
Targeted lung denervation continues to evolve as a bronchoscopic treatment option for select COPD phenotypes, requiring careful patient selection.